Ching‐Ju Shen

LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells

Ching‐Ju Shen, Ya-Min Cheng, Chiu-Lin Wang · Journal of drug targeting · 2017 · 162 citations

Life Sciences, Molecular Biology, Oncology +17

MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer

Ching‐Ju Shen, Yu-Ling Kuo, Chien‐Chung Chen et al. · PLoS ONE · 2017 · 92 citations · Full text

Medicine, Cancer Biology, Oncology +16

MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM

Ming-Jenn Chen, Ya-Min Cheng, Chien‐Chung Chen et al. · Biochemical and Biophysical Research Communications · 2017 · 56 citations

Life Sciences, Molecular Biology, Oncology +14

The concentrations of visfatin in the follicular fluids of women undergoing controlled ovarian stimulation are correlated to the number of oocytes retrieved

Ching‐Ju Shen, Eing‐Mei Tsai, Jau-Nan Lee et al. · Fertility and Sterility · 2009 · 53 citations · Full text

Medicine, Gynecology, Obstetrics +13

Melatonin Suppresses the Growth of Ovarian Cancer Cell Lines (OVCAR-429 and PA-1) and Potentiates the Effect of G1 Arrest by Targeting CDKs

Ching‐Ju Shen, Chi‐Chang Chang, Yi-Tz Chen et al. · International Journal of Molecular Sciences · 2016 · 47 citations · Full text

Medicine, Oncology, Pharmacology +14